相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunogenicity in Protein and Peptide Based-Therapeutics: An Overview
L. Fernandez et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2018)
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3-LBA, biomarkers and immunogenicity)
Susan Richards et al.
BIOANALYSIS (2016)
A fit-for-purpose strategy for the risk-based immunogenicity testing of biotherapeutics: a European industry perspective
Cathelijne Kloks et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
Japanese bioanalytical method validation guideline: the world's first regulatory guideline dedicated to ligand-binding assays
Mami Imazato-Hirano et al.
BIOANALYSIS (2015)
Assessment and Reporting of the Clinical Immunogenicity of Therapeutic Proteins and Peptides-Harmonized Terminology and Tactical Recommendations
G. Shankar et al.
AAPS JOURNAL (2014)
Theoretical Considerations and Practical Approaches to Address the Effect of Anti-drug Antibody (ADA) on Quantification of Biotherapeutics in Circulation
Marian Kelley et al.
AAPS JOURNAL (2013)
Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
Peter J. K. van Meer et al.
MABS (2013)
Immunogenicity to Biologics: Mechanisms, Prediction and Reduction
Swaminathan Sethu et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2012)
Influence of the HLA-DRB1 Genotype on Antibody Development to Interferon Beta in Multiple Sclerosis
Dorothea Buck et al.
ARCHIVES OF NEUROLOGY (2011)
Comparison of assay formats for drug-tolerant immunogenicity testing
Anthony M. Butterfield et al.
BIOANALYSIS (2010)
The association of anti-r-HuEpo-associated pure red cell aplasia with HLA-DRB1*09-DQB1*0309
Kearkiat Praditpornsilpa et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products
Eugen Koren et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products
Gopi Shankar et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)
Detection of antibodies against therapeutic proteins in the presence of residual therapeutic protein using a solid-phase extraction with acid dissociation (SPEAD) sample treatment prior to ELISA
Holly W. Smith et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2007)
A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs
Gopi Shankar et al.
NATURE BIOTECHNOLOGY (2007)
Immunogenicity testing by electrochemiluminescent detection for antibodies directed against therapeutic human monoclonal antibodies
M Moxness et al.
CLINICAL CHEMISTRY (2005)
An acid dissociation bridging ELISA for detection of antibodies directed against therapeutic proteins in the presence of antigen
A Patton et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
分享论文
